Global HLA Testing Market Research Report 2024

Publication ID:

PB502249194

Publication Date:

February 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A blood test equipment that identifies antigens on the surface of cells and tissues.
The global HLA Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for HLA Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HLA Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HLA Testing in Medical Diagnostic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HLA Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HLA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HLA Testing.
Report Scope
The HLA Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HLA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HLA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Segment by Type
Reagents Testing
Instruments Testing
Segment by Application
Medical Diagnostic
Research Laboratories & Academic Institutes
Commercial Service
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HLA Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HLA Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents Testing
1.2.3 Instruments Testing
1.3 Market by Application
1.3.1 Global HLA Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Diagnostic
1.3.3 Research Laboratories & Academic Institutes
1.3.4 Commercial Service
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HLA Testing Market Perspective (2019-2030)
2.2 HLA Testing Growth Trends by Region
2.2.1 Global HLA Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HLA Testing Historic Market Size by Region (2019-2024)
2.2.3 HLA Testing Forecasted Market Size by Region (2025-2030)
2.3 HLA Testing Market Dynamics
2.3.1 HLA Testing Industry Trends
2.3.2 HLA Testing Market Drivers
2.3.3 HLA Testing Market Challenges
2.3.4 HLA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HLA Testing Players by Revenue
3.1.1 Global Top HLA Testing Players by Revenue (2019-2024)
3.1.2 Global HLA Testing Revenue Market Share by Players (2019-2024)
3.2 Global HLA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HLA Testing Revenue
3.4 Global HLA Testing Market Concentration Ratio
3.4.1 Global HLA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HLA Testing Revenue in 2023
3.5 HLA Testing Key Players Head office and Area Served
3.6 Key Players HLA Testing Product Solution and Service
3.7 Date of Enter into HLA Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HLA Testing Breakdown Data by Type
4.1 Global HLA Testing Historic Market Size by Type (2019-2024)
4.2 Global HLA Testing Forecasted Market Size by Type (2025-2030)
5 HLA Testing Breakdown Data by Application
5.1 Global HLA Testing Historic Market Size by Application (2019-2024)
5.2 Global HLA Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HLA Testing Market Size (2019-2030)
6.2 North America HLA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HLA Testing Market Size by Country (2019-2024)
6.4 North America HLA Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HLA Testing Market Size (2019-2030)
7.2 Europe HLA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HLA Testing Market Size by Country (2019-2024)
7.4 Europe HLA Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HLA Testing Market Size (2019-2030)
8.2 Asia-Pacific HLA Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HLA Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific HLA Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HLA Testing Market Size (2019-2030)
9.2 Latin America HLA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HLA Testing Market Size by Country (2019-2024)
9.4 Latin America HLA Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HLA Testing Market Size (2019-2030)
10.2 Middle East & Africa HLA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HLA Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa HLA Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific HLA Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in HLA Testing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 F. Hoffman-La Roche
11.2.1 F. Hoffman-La Roche Company Detail
11.2.2 F. Hoffman-La Roche Business Overview
11.2.3 F. Hoffman-La Roche HLA Testing Introduction
11.2.4 F. Hoffman-La Roche Revenue in HLA Testing Business (2019-2024)
11.2.5 F. Hoffman-La Roche Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories HLA Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in HLA Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Detail
11.4.2 QIAGEN N.V. Business Overview
11.4.3 QIAGEN N.V. HLA Testing Introduction
11.4.4 QIAGEN N.V. Revenue in HLA Testing Business (2019-2024)
11.4.5 QIAGEN N.V. Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina HLA Testing Introduction
11.5.4 Illumina Revenue in HLA Testing Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Immucor
11.6.1 Immucor Company Detail
11.6.2 Immucor Business Overview
11.6.3 Immucor HLA Testing Introduction
11.6.4 Immucor Revenue in HLA Testing Business (2019-2024)
11.6.5 Immucor Recent Development
11.7 CareDx
11.7.1 CareDx Company Detail
11.7.2 CareDx Business Overview
11.7.3 CareDx HLA Testing Introduction
11.7.4 CareDx Revenue in HLA Testing Business (2019-2024)
11.7.5 CareDx Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Detail
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson HLA Testing Introduction
11.8.4 Becton Dickinson Revenue in HLA Testing Business (2019-2024)
11.8.5 Becton Dickinson Recent Development
11.9 Hologic
11.9.1 Hologic Company Detail
11.9.2 Hologic Business Overview
11.9.3 Hologic HLA Testing Introduction
11.9.4 Hologic Revenue in HLA Testing Business (2019-2024)
11.9.5 Hologic Recent Development
11.10 GenDx
11.10.1 GenDx Company Detail
11.10.2 GenDx Business Overview
11.10.3 GenDx HLA Testing Introduction
11.10.4 GenDx Revenue in HLA Testing Business (2019-2024)
11.10.5 GenDx Recent Development
11.11 Biofortuna
11.11.1 Biofortuna Company Detail
11.11.2 Biofortuna Business Overview
11.11.3 Biofortuna HLA Testing Introduction
11.11.4 Biofortuna Revenue in HLA Testing Business (2019-2024)
11.11.5 Biofortuna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂